BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 25820757)

  • 1. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
    Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
    Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.
    Bajaj JS; Hylemon PB; Ridlon JM; Heuman DM; Daita K; White MB; Monteith P; Noble NA; Sikaroodi M; Gillevet PM
    Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(6):G675-85. PubMed ID: 22821944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered profile of human gut microbiome is associated with cirrhosis and its complications.
    Bajaj JS; Heuman DM; Hylemon PB; Sanyal AJ; White MB; Monteith P; Noble NA; Unser AB; Daita K; Fisher AR; Sikaroodi M; Gillevet PM
    J Hepatol; 2014 May; 60(5):940-7. PubMed ID: 24374295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus.
    Bajaj JS; Betrapally NS; Hylemon PB; Thacker LR; Daita K; Kang DJ; White MB; Unser AB; Fagan A; Gavis EA; Sikaroodi M; Dalmet S; Heuman DM; Gillevet PM
    Sci Rep; 2015 Dec; 5():18559. PubMed ID: 26692421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning.
    Saboo K; Petrakov NV; Shamsaddini A; Fagan A; Gavis EA; Sikaroodi M; McGeorge S; Gillevet PM; Iyer RK; Bajaj JS
    J Hepatol; 2022 Mar; 76(3):600-607. PubMed ID: 34793867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of microbiome in patients with decompensated cirrhosis.
    Oikonomou T; Papatheodoridis GV; Samarkos M; Goulis I; Cholongitas E
    World J Gastroenterol; 2018 Sep; 24(34):3813-3820. PubMed ID: 30228776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis.
    Ahluwalia V; Betrapally NS; Hylemon PB; White MB; Gillevet PM; Unser AB; Fagan A; Daita K; Heuman DM; Zhou H; Sikaroodi M; Bajaj JS
    Sci Rep; 2016 May; 6():26800. PubMed ID: 27225869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis.
    Acharya C; Betrapally NS; Gillevet PM; Sterling RK; Akbarali H; White MB; Ganapathy D; Fagan A; Sikaroodi M; Bajaj JS
    Aliment Pharmacol Ther; 2017 Jan; 45(2):319-331. PubMed ID: 27868217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary microbiota-immune profiling in cirrhosis: could this be the noninvasive strategy that will revolutionize prognostication in hepatology?
    Patel VC; Shawcross DL
    Hepatology; 2015 Oct; 62(4):1001-3. PubMed ID: 25998053
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.
    Bajaj JS; Fagan A; White MB; Wade JB; Hylemon PB; Heuman DM; Fuchs M; John BV; Acharya C; Sikaroodi M; Gillevet PM
    Am J Gastroenterol; 2019 Jul; 114(7):1080-1090. PubMed ID: 30816877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis.
    Bajaj JS; Matin P; White MB; Fagan A; Deeb JG; Acharya C; Dalmet SS; Sikaroodi M; Gillevet PM; Sahingur SE
    Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G824-G837. PubMed ID: 30118351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linkage of gut microbiome with cognition in hepatic encephalopathy.
    Bajaj JS; Ridlon JM; Hylemon PB; Thacker LR; Heuman DM; Smith S; Sikaroodi M; Gillevet PM
    Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G168-75. PubMed ID: 21940902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microbiota in hepatic encephalopathy.
    Bajaj JS
    Gut Microbes; 2014; 5(3):397-403. PubMed ID: 24690956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome.
    Sung CM; Lin YF; Chen KF; Ke HM; Huang HY; Gong YN; Tsai WS; You JF; Lu MJ; Cheng HT; Lin CY; Kuo CJ; Tsai IJ; Hsieh SY
    Cell Mol Gastroenterol Hepatol; 2019; 8(2):301-318.e2. PubMed ID: 31004827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered Microbiome in Patients With Cirrhosis and Complications.
    Acharya C; Bajaj JS
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):307-321. PubMed ID: 30099098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients.
    Bajaj JS; Sterling RK; Betrapally NS; Nixon DE; Fuchs M; Daita K; Heuman DM; Sikaroodi M; Hylemon PB; White MB; Ganapathy D; Gillevet PM
    Aliment Pharmacol Ther; 2016 Sep; 44(6):638-43. PubMed ID: 27417456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Enteric Protist Blastocystis spp. and Gut Microbiota with Hepatic Encephalopathy.
    Yildiz S; Doğan İ; Doğruman-Al F; Nalbantoğlu U; Üstek D; Sarzhanov F; Yildirim S
    J Gastrointestin Liver Dis; 2016 Dec; 25(4):489-497. PubMed ID: 27981305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis.
    Bajaj JS; Fagan A; Sikaroodi M; White MB; Sterling RK; Gilles H; Heuman D; Stravitz RT; Matherly SC; Siddiqui MS; Puri P; Sanyal AJ; Luketic V; John B; Fuchs M; Ahluwalia V; Gillevet PM
    Liver Transpl; 2017 Jul; 23(7):907-914. PubMed ID: 28240840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
    Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota: its role in hepatic encephalopathy.
    Rai R; Saraswat VA; Dhiman RK
    J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S29-36. PubMed ID: 26041954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.